RYLEVO, created in 2011 (United Kingdom), from 1722 sister brands and 17477 competing brands. RYLEVO is owned by GSK PLC, listed on the stock exchange of Francfort The International Securities Identification Number (ISIN) of GSK PLC is GB00BN7SWP63. RYLEVO belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
GSK PLC
(RYLEVO)
over 5 years*
EUR 16.12